Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00975871
Other study ID # 0961172000
Secondary ID
Status Completed
Phase N/A
First received September 11, 2009
Last updated October 21, 2009
Start date October 2007
Est. completion date April 2009

Study information

Verified date October 2009
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Observational

Clinical Trial Summary

Livedo vasculitis is disease with recurrent courses of painful foot or ankle ulcerations, followed by healed white scars. The actual mechanism of its pathophysiology is not yet clear. It has been reported to be associated with some gene mutations, for example, factor V Leiden gene. This study is aimed to find the possible relation of these gene mutations in Taiwanese patients.


Description:

Livedo vasculitis is a chronic, recurrent painful ulcerations on the ankles and feet. This chronic disease is characterized by healed white, atrophic scars named atrophie blanche. The histopathological exam on the lesion site reveals fibrin deposition within the vessel walls. It has been reported to be related to factor V Leiden mutation (heterozygous) (22.2%), prothrombin G20210A gene mutation (8.3%), PAI promotor 4G/4G genotype and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in about total 30% livedo vasculitis patients. This study is trying to find the correlation between Taiwanese patients and these four genes.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date April 2009
Est. primary completion date April 2009
Accepts healthy volunteers No
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Clinical diagnosis of livedo vasculitis

Exclusion Criteria:

- No special exclusion criteria

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

See also
  Status Clinical Trial Phase
Completed NCT05878327 - Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With Thrombophilia